- 4 December 2019
- Transport / Logistics Services
Wes Wheeler is to be President of UPS global Healthcare and Life Sciences (HCLS) unit. He is moving from his current role of UPS wholly owned subsidiary Marken effective immediately.
The HCLS unit is the result of a company wide restructure where all healthcare and life sciences operation, as well as commercial groups are to be led from.
“We are pleased to appoint Wes to this very important leadership role,” said David Abney, UPS chairman and CEO. “He has an impressive career and deep experience in the clinical trials, pharmaceutical, biotech and medical device industries. His expertise will complement our strategic healthcare growth and technology initiatives.”
UPS’s HCLS unit provides extensive supply chain management, cold chain, clinical trials, global transportation and other critical healthcare service operations. The unit includes Marken, Polar Speed, and the company’s 114 healthcare-dedicated facilities. The HCLS unit has a dedicated and healthcare-trained salesforce and customer support teams throughout the company’s global network.
“Healthcare and life sciences have many complex supply chain challenges and opportunities,” Abney continued. “We look forward to Wes continuing our commitment to putting healthcare customers’ needs first, while ensuring UPS meets supply chain demands with quality assurance, innovation and control.”